CELH
Celsius Holdings, Inc.
CELH has the edge over CENTA overall, supported by stronger fundamentals and stronger valuation.
CENTA
Central Garden & Pet Company
CENTA has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CENTA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
CENTA's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
CENTA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $40.37 | — |
| Cheap | 14x | $37.59 | -6.9% |
| Fair | 16x | $43.69 | +8.2% |
| Current | 16x | $40.37 | — |
| Expensive | 19x | $51.07 | +26% |
Historical ranges are pointers, not guarantees.
CENTA has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over CENTA on the outlook, with more favorable revenue and profitability expectations.
CENTA Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect CENTA's earnings to grow, with its revenue and profitability holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
CENTA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.08 | +15% |
| Q2 2026 | $2.68 | +22% |
| Q1 2026 | $2.75 | +47% |
| Q4 2025 | $2.45 | +35% |
| Q3 2025 | $2.55 | +57% |
| Q2 2025 | $2.20 | +1.4% |
| Q1 2025 | $1.87 | -16% |
| Q4 2024 | $1.82 | -9.9% |
| Q3 2024 | $1.62 | -14% |
CENTA has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over CENTA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over CENTA on profitability, with a higher operating margin.
CENTA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $882.4M | -8.2% |
| Q1 2026 | $906.2M | +8.7% |
| Q4 2025 | $617.4M | -6% |
| Q3 2025 | $678.2M | +1.3% |
| Q2 2025 | $960.9M | -3.6% |
| Q1 2025 | $833.5M | -7.4% |
| Q4 2024 | $656.4M | +3.5% |
| Q3 2024 | $669.5M | -11% |
CENTA's revenue grew through 2022 and has held roughly level since: $882M last quarter, down 8.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | +0.2 points |
| Q1 2026 | 13% | +1.4 points |
| Q4 2025 | 2.7% | -1.6 points |
| Q3 2025 | -0.9% | +3.9 points |
| Q2 2025 | 14% | +2.4 points |
| Q1 2025 | 11% | +0.8 points |
| Q4 2024 | 4.3% | +2.9 points |
| Q3 2024 | -4.8% | -6.1 points |
CENTA's operating margin was 14% last quarter, about level with the same quarter a year ago, near the top of its range since 2019.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over CENTA on cash flow, with more consistent year-over-year improvement.
CENTA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $314.9M | +25% |
| Q1 2026 | -$60.1M | -$2.6M |
| Q4 2025 | -$81M | -$6.1M |
| Q3 2025 | $171.9M | -11% |
| Q2 2025 | $251.7M | -7.6% |
| Q1 2025 | -$57.5M | -$23.7M |
| Q4 2024 | -$74.9M | +$5M |
| Q3 2024 | $193M | +37% |
CENTA generated $346M in free cash flow over the past year, up 11% from the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over CENTA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
CENTA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +78K shares |
| 1 year | -1.1% | -663K shares |
| 3 years | -7.2% | -4.8M shares |
| 5 years | -11% | -7.6M shares |
| Available history | -12% | -8.8M shares |
CENTA has 62M diluted shares, down 1.1% from a year ago, with $29M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $951,000 |
| Q1 2026 | $7.9M |
| Q4 2025 | $20M |
| Q3 2025 | $332,000 |
| Q2 2025 | $56.5M |
| Q1 2025 | $44.2M |
| Q4 2024 | $54M |
| Q3 2024 | $9.3M |
CENTA spent $29M buying back its own shares over the past year, down 82% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over CENTA on leverage, with a lower net debt burden relative to earnings.
CENTA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 0.9x | Very low |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 1.9x | Healthy |
| Q3 2024 | 1.6x | Healthy |
CENTA's net debt is less than a year of its operating earnings (EBITDA), down from 1.5 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
CENTA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.8 | Neutral |
| Stochastic | 79.6 | Neutral |
CENTA's weekly RSI is 65 (neutral) and its Stochastic is 80 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
CENTA PE vs Consumer Defensive Sector
| Metric | CENTA | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 19x | 20% below |
| PE % | 41 | 18 | 23 pts above |
CENTA has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
CENTA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $37.4 | 8% above |
| 20 week MA | $37.4 | 7.9% above |
| 50 week MA | $34.7 | 16% above |
| 100 week MA | $33.1 | 22% above |
| 200 week MA | $32.9 | 23% above |
CENTA has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
CENTA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.8 | $27.9 | +17% |
| 2021 | $27.9 | $37.5 | +34% |
| 2022 | $37.5 | $28.9 | -23% |
| 2023 | $28.9 | $35.2 | +22% |
| 2024 | $35.2 | $33.3 | -5.5% |
| 2025 | $33.3 | $29.6 | -11% |
| 2026 YTD | $29.6 | $40.4 | +36% |
CENTA has the edge over CELH on returns for 2026, with the stronger performance.